Father of LSD Turns 100
Swiss Chemist Albert Hofmann Still Lauds Acid's Potential as January Marks 20 Years of "Just Say No." Jazz musician Kyle Bronsdon commemorates the scientist's life and work in "A Model Psychosis." Profits will go to a new printing of Hofmann's autobiography.
Los Angeles, CA (PRWEB) January 10, 2006
Doctors, artists and iconoclasts alike are preparing to celebrate tomorrow's 100th birthday of Dr. Albert Hofmann, best known for his discovery of D-lysergic acid diethylamide or LSD.
Hofmann is pleased by current trends towards allowing scientists to continue the promising results of early LSD research, which came to an abrupt halt due to political pressures in 1970. The Nobel Prize Committee Member laments the irresponsible social use of his discovery that brought about the restrictions facing the medical profession for the last 30 years.
Coincidentally, this week will also see the 20th anniversary of President and Mrs. Reagan's "Just Say No" national address of September 14th, 1986.
Hofmann personally encouraged jazz songwriter Kyle Bronsdon to deal with the stigma and "prevailing misunderstanding in the general public regarding these kinds of 'drugs.'" Bronsdon honors the chemist's life and work and explores the dark history of the drug war in his new CD, "A Model Psychosis," released today on his Vitalegacy label.
The musician will be donating proceeds of the album to the Multidisciplinary Association for Psychedelic Studies, a non-profit organization that helps researchers obtain funding and approval for legitimate studies of LSD, marijuana and other psychedelics. The proceeds will be used to re-print Hofmann's book, "LSD: My Problem Child," which has been out of print in English for years.
Kyle Bronsdon, while generally not a political type of songwriter, is passionate about two causes:
Media consolidation/deregulation and the drug war. The current administration has given his usually whimsical style of jazz and blues a distinctly cynical bent.
Http://www. swingdrummer. com (http://www. swingdrummer. com)
The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based, IRS-approved 501 (c) (3) non-profit research and educational organization. We assist scientists to design, fund, obtain approval for and report on studies into the risks and benefits of MDMA, psychedelic drugs and marijuana. MAPS' mission is to sponsor scientific research designed to develop psychedelics and marijuana into FDA-approved prescription medicines, and to educate the public honestly about the risks and benefits of these drugs.
Http://www. maps. org (http://www. maps. org)
###
